Prescribing drugs off label can sometimes be the best option for patients. It’s an unavoidable part of medicine. Some of the most important discoveries have been accidental discoveries in which a patient has benefited from an off-label use of a drug.

Currently, federal law allows manufacturers to respond to unsolicited questions from physicians, share peer-reviewed articles and sponsor continuing medical education courses. Congress has proposed two bills that are designed to expand those rules.
Read more at Dermatology Times >>